dantetzl – Hibiscus BioVentures

3DBio Therapeutics All

3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial

All

Innoforce and Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies

All

Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research

All

connectRN raises $76M for healthcare worker staffing, networking

All

Cellevolve Launches with Acclaimed Investors and Pivotal Manufacturing Partnership, Focused on Accelerating the Commercialization of Novel Cell Therapies

All NexImmune

NexImmune Announces Pricing of Upsized Initial Public Offering

All NexImmune

Immunotherapy Veteran Robert Knight, MD, Joins NexImmune as Chief Medical Office

All

Bayer and Northpond Ventures Lead USD 55 million Series A Financing Round for Triumvira Immunologics

All NexImmune

NexImmune to Present at the Jefferies Virtual Healthcare Conference

All Cereno Scientific

The Board and Chief Executive Officer of Cereno Scientific AB here with present the Interim Report for the first quarter 2020

© 2022 Hibiscus BioVentures.